Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa
Ammar Almaaytah1,2 1Faculty of Pharmacy, Middle East University, Amman, Jordan; 2Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JordanCorrespondence: Ammar Almaaytah Tel +962777658820Email aalmaaytah@meu.edu.joIntroduction: Biosimilars of monoclonal antibodies are being rap...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2020-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|